InflaRx Statistics
Total Valuation
InflaRx has a market cap or net worth of $70.46 million. The enterprise value is $19.53 million.
Important Dates
The last earnings date was Monday, November 10, 2025, before market open.
| Earnings Date | Nov 10, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
InflaRx has 67.75 million shares outstanding. The number of shares has increased by 9.45% in one year.
| Current Share Class | 67.75M |
| Shares Outstanding | 67.75M |
| Shares Change (YoY) | +9.45% |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 6.38% |
| Owned by Institutions (%) | 17.83% |
| Float | 56.94M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 955.62 |
| Forward PS | 77.90 |
| PB Ratio | 1.32 |
| P/TBV Ratio | 1.33 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 264.95 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 3.33, with a Debt / Equity ratio of 0.02.
| Current Ratio | 3.33 |
| Quick Ratio | 2.43 |
| Debt / Equity | 0.02 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -1,774.05 |
Financial Efficiency
Return on equity (ROE) is -72.49% and return on invested capital (ROIC) is -52.38%.
| Return on Equity (ROE) | -72.49% |
| Return on Assets (ROA) | -40.69% |
| Return on Invested Capital (ROIC) | -52.38% |
| Return on Capital Employed (ROCE) | -102.27% |
| Revenue Per Employee | $996 |
| Profits Per Employee | -$635,850 |
| Employee Count | 74 |
| Asset Turnover | 0.00 |
| Inventory Turnover | 0.71 |
Taxes
In the past 12 months, InflaRx has paid $14,410 in taxes.
| Income Tax | 14,410 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -55.36% in the last 52 weeks. The beta is 1.46, so InflaRx's price volatility has been higher than the market average.
| Beta (5Y) | 1.46 |
| 52-Week Price Change | -55.36% |
| 50-Day Moving Average | 1.18 |
| 200-Day Moving Average | 1.16 |
| Relative Strength Index (RSI) | 44.73 |
| Average Volume (20 Days) | 644,267 |
Short Selling Information
| Short Interest | 2.75M |
| Short Previous Month | 2.17M |
| Short % of Shares Out | 4.33% |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 3.13 |
Income Statement
In the last 12 months, InflaRx had revenue of $73,729 and -$47.05 million in losses. Loss per share was -$0.73.
| Revenue | 73,729 |
| Gross Profit | -6.06M |
| Operating Income | -55.32M |
| Pretax Income | -47.04M |
| Net Income | -47.05M |
| EBITDA | -55.31M |
| EBIT | -55.32M |
| Loss Per Share | -$0.73 |
Full Income StatementBalance Sheet
The company has $52.06 million in cash and $1.14 million in debt, with a net cash position of $50.92 million or $0.75 per share.
| Cash & Cash Equivalents | 52.06M |
| Total Debt | 1.14M |
| Net Cash | 50.92M |
| Net Cash Per Share | $0.75 |
| Equity (Book Value) | 53.23M |
| Book Value Per Share | 0.79 |
| Working Capital | 52.11M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$49.87 million and capital expenditures -$153,143, giving a free cash flow of -$49.61 million.
| Operating Cash Flow | -49.87M |
| Capital Expenditures | -153,143 |
| Free Cash Flow | -49.61M |
| FCF Per Share | -$0.73 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | -75,034.07% |
| Pretax Margin | -63,799.13% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
InflaRx does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -9.45% |
| Shareholder Yield | -9.45% |
| Earnings Yield | -66.78% |
| FCF Yield | -70.40% |
Analyst Forecast
The average price target for InflaRx is $8.50, which is 717.31% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $8.50 |
| Price Target Difference | 717.31% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 6 |
| Revenue Growth Forecast (5Y) | 146.72% |
| EPS Growth Forecast (5Y) | -19.84% |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
InflaRx has an Altman Z-Score of -6.81. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -6.81 |
| Piotroski F-Score | n/a |
